The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial
Abstract
CONTEXT: Plasma homocysteine level has been recognized as an important cardiovascular risk factor that predicts adverse cardiac events in patients with established coronary atherosclerosis and influences restenosis rate after percutaneous coronary intervention. OBJECTIVE: To evaluate the effect of homocysteine-lowering therapy on clinical outcome after percutaneous coronary intervention. DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind placebo-controlled trial involving 553 patients referred to the University Hospital in Bern, Switzerland, from May 1998 to April 1999 and enrolled after successful angioplasty of at least 1 significant coronary stenosis (> or = 50%). INTERVENTION: Participants were randomly assigned to receive a combination of folic acid (1 mg/d), vitamin B12 (cyanocobalamin, 400 micro g/d), and vitamin B6 (pyridoxine hydrochloride, 10 mg/d) (n = 272) or placebo (n = 281) for 6 months. MAIN OUTCOME MEASURE: Composite end point of major adverse events defined as death, nonfatal myocardial infarction, and need for repeat revascularization, evaluated at 6 months and 1 year. RESULTS: After a mean (SD) follow-up of 11 (3) months, the composite end point was significantly lower at 1 year in patients treated with homocysteine-lowering therapy (15.4% vs 22.8%; relative risk [RR], 0.68; 95% confidence interval [CI], 0.48-0.96; P =.03), primarily due to a reduced rate of target lesion revascularization (9.9% vs 16.0%; RR, 0.62; 95% CI, 0.40-0.97; P =.03). A nonsignificant trend was seen toward fewer deaths (1.5% vs 2.8%; RR, 0.54; 95% CI, 0.16-1.70; P =.27) and nonfatal myocardial infarctions (2.6% vs 4.3%; RR, 0.60; 95% CI, 0.24-1.51; P =.27) with homocysteine-lowering therapy. These findings remained unchanged after adjustment for potential confounders. CONCLUSION: Homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 significantly decreases the incidence of major adverse events after percutaneous coronary intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Ellis, S. G., Vandormael, M. G., Cowley, M. J., DiSciascio, G., Deligonul, U., Topol, E. J., & Bulle, T. M. (1990) · Circulation · doi:10.1161/01.cir.82.4.1193 · Cited by 1,350
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
Starkebaum, G., & Harlan, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112442 · Cited by 822
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.274.13.1049 · Cited by 767
Hyperhomocyst(e)inemia Is Associated With Impaired Endothelium-Dependent Vasodilation in Humans
Tawakol, A., Omland, T., Gerhard, M., Wu, J. T., & Creager, M. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1119 · Cited by 684
Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
Ubbink, J. B., Hayward Vermaak, W. J., & Bissbort, S. (1991) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80407-4 · Cited by 678
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
Upchurch, G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney, J. F., & Loscalzo, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17012 · Cited by 668
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Robinson, K., Arheart, K., Refsum, H., Brattström, L., Boers, G., Ueland, P., Rubba, P., Palma-Reis, R., Meleady, R., Daly, L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.5.437 · Cited by 550
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., & Hess, O. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011364 · Cited by 532
Self-citationHyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans
Woo, K. S., Chook, P., Lolin, Y. I., Cheung, A. S. P., Chan, L. T., Sun, Y. Y., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1997) · Circulation · doi:10.1161/01.cir.96.8.2542 · Cited by 486
Campbell, M. J., Julious, S. A., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.311.7013.1145 · Cited by 476
Rodgers, G., & Conn, M. (1990) · Blood · doi:10.1182/blood.v75.4.895.895 · Cited by 398
Hirshfeld, J. W., Schwartz, J. S., Jugo, R., Macdonald, R. G., Goldberg, S., Savage, M. P., Bass, T. A., Vetrovec, G., Cowley, M., Taussig, A. S., et al. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90783-6 · Cited by 391
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
Verhaar, M. C., Wever, R. M. F., Kastelein, J. J. P., van Dam, T., Koomans, H. A., & Rabelink, T. J. (1998) · Circulation · doi:10.1161/01.cir.97.3.237 · Cited by 351
Poddar, R., Sivasubramanian, N., DiBello, P. M., Robinson, K., & Jacobsen, D. W. (2001) · Circulation · doi:10.1161/01.cir.103.22.2717 · Cited by 344
Vermeulen, E., Stehouwer, C., Twisk, J., van den Berg, M., de Jong, S., Mackaay, A., van Campen, C., Visser, F., Jakobs, C., Bulterijs, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07391-2 · Cited by 322
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia
Woo, K. S., Chook, P., Lolin, Y. I., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00469-6 · Cited by 303
Majors, A., Ehrhart, L. A., & Pezacka, E. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2074 · Cited by 261
Doshi, S. N., McDowell, I. F. W., Moat, S. J., Lang, D., Newcombe, R. G., Kredan, M. B., Lewis, M. J., & Goodfellow, J. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092000 · Cited by 248
Homocysteine and cardiovascular disease:
Mangoni, A. A., & Jackson, S. H. D. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01021-5 · Cited by 242
Tissue Plasminogen Activator Binding to the Annexin II Tail Domain
Hajjar, K. A., Mauri, L., Jacovina, A. T., Zhong, F., Mirza, U. A., Padovan, J. C., & Chait, B. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9987 · Cited by 236
Title, L. M., Cummings, P. M., Giddens, K., Genest, J. J., & Nassar, B. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00809-3 · Cited by 227
Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels
Voutilainen, S., Morrow, J. D., Roberts, L. J., Alfthan, G., Alho, H., Nyyssönen, K., & Salonen, J. T. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1263 · Cited by 205
Stiko-Rahm, A., Hultgårdh-Nilsson, A., Regnström, J., Hamsten, A., & Nilsson, J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1099 · Cited by 166
Hackam, D. G., Peterson, J. C., & Spence, J. D. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00180-6 · Cited by 145
Stubbs, P. J., Al-Obaidi, M., Conroy, R. M., MusB, Collinson, P. O., MRCPath, M., Graham, I. M., Frcpi, & Noble, M. I. M. (2000) · Circulation · doi:10.1161/01.cir.102.6.605 · Cited by 120
Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis
Khajuria, A., & Houston, D. S. (2000) · Blood · doi:10.1182/blood.v96.3.966 · Cited by 113
Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis
Ku, G., Doherty, N. S., Wolos, J. A., Jackson, R. L., Schmidt, L., & Hendricks, D. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80057-2 · Cited by 97
Plasma homocysteine levels and mortality in patients with coronary artery disease
(1998) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(98)90076-3 · Cited by 84
The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis
Chao, C., Tsai, H.-H., Lee, C., Hsu, S.-M., Kao, J., Chien, K., Sung, F., & Lee, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00208-7 · Cited by 72
Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty
Schnyder, G., Roffi, M., Flammer, Y., Pin, R., & Hess, O. M. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2962 · Cited by 70
Self-citationHOMOCYSTEINE, B VITAMINS, AND CORONARY ARTERY DISEASE
Seshadri, N., & Robinson, K. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70215-7 · Cited by 65
Homocysteine as a Risk Factor for Restenosis after Coronary Angioplasty
Kurihara, H., Kuwaki, T., Hamada, C., Kitaoka, M., Suzuki, S., Yazaki, Y., Nagai, R., & Morita, H. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613962 · Cited by 49
Association of plasma homocysteine with the number of major coronary arteries severely narrowed
Schnyder, G., Pin, R., Roffi, M., Flammer, Y., & Hess, O. M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01983-x · Cited by 42
Self-citation
Cited by
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., Grady, D., Haan, C. K., Hayes, S. N., Judelson, D. R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000114834.85476.81 · Cited by 917
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.020 · Cited by 757
Brunner, H., Cockcroft, J. R., Deanfield, J., Donald, A., Ferrannini, E., Halcox, J., Kiowski, W., L??scher, T. F., Mancia, G., Natali, A., et al. (2005) · Journal of Hypertension · doi:10.1097/00004872-200502000-00001 · Cited by 753
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Metadata
- Authors
- Schnyder, G., Roffi, M., Flammer, Y., Pin, R., & Hess, O. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-08-28
- Volume
- 288
- Issue
- 8
- Pages
- 973
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2031093055
- Cited by
- 379
- References
- 40
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.